ORASURE TECHNOLOGIES INC (OSUR) competitors & alternatives
Health Care · NASDAQ
ORASURE TECHNOLOGIES INC (OSUR)'s top competitors and alternatives — its most similar public companies — include Becton Dickinson (BDX), Bio-Rad Laboratories (BIO), QUIDELORTHO CORP (QDEL), Abbott Laboratories (ABT), Qiagen (QGEN), Idexx Laboratories (IDXX), Insight Molecular Diagnostics Inc. (IMDX), Waters Corporation (WAT), QUANTERIX CORP (QTRX), MYRIAD GENETICS INC (MYGN), Labcorp (LH) and FULGENT GENETICS INC (FLGT). These are ORASURE TECHNOLOGIES INC's closest public-company peers by sub-industry, sector and business themes and is informational only — not financial advice.
Top OSUR competitors & alternatives
-
Becton DickinsonBDXHealth Care
BD is a leading global medical technology company providing essential medical devices, diagnostic systems, and laboratory solutions to healthcare providers and…
$153.16 (as of 2026-07-22) · market cap $42.2B
-
Bio-Rad LaboratoriesBIOHealth Care
A multinational life science and clinical diagnostics company providing research tools, diagnostic test systems, and consumables to laboratories and…
$305.96 (as of 2026-07-22) · market cap $8.2B
-
QUIDELORTHO CORPQDELHealth Care
Global diagnostics company providing immunoassay, molecular testing, clinical chemistry, and transfusion medicine solutions across labs, point-of-care, and…
$16.68 (as of 2026-07-22) · market cap $1.1B
-
Abbott LaboratoriesABTHealth Care
Abbott Laboratories is a diversified healthcare giant providing a broad portfolio of diagnostic systems, medical devices, nutritional products, and established…
$100.57 (as of 2026-07-22) · market cap $175.1B
-
QiagenQGENHealth Care
QIAGEN supplies essential molecular diagnostic and sample preparation tools that enable laboratories and clinicians to detect, analyze, and validate genetic…
$40.57 (as of 2026-07-22) · market cap $8.4B
-
Idexx LaboratoriesIDXXHealth Care
IDEXX supplies diagnostic instruments, tests, and software to companion animal veterinary practices, plus water quality and livestock/dairy diagnostics.
$545.00 (as of 2026-07-22) · market cap $43.4B
-
Insight Molecular Diagnostics Inc.IMDXHealth Care
iMDx develops decentralized molecular diagnostic kits for transplant organ rejection monitoring using donor-derived cell-free DNA biomarkers, enabling in-house…
$4.99 (as of 2026-07-22) · market cap $165M
-
Waters CorporationWATHealth Care
A leading global analytical instruments and life sciences company combining chromatography, mass spectrometry, and diagnostic solutions following a…
$370.82 (as of 2026-07-22) · market cap $35.9B
-
QUANTERIX CORPQTRXHealth Care
Quanterix develops ultra-sensitive protein detection and spatial tissue analysis platforms for biomarker discovery and early disease diagnostics, with recent…
$3.84 (as of 2026-07-22) · market cap $181M
-
MYRIAD GENETICS INCMYGNHealth Care
Myriad Genetics is a molecular diagnostics and precision medicine company that develops genetic tests for cancer screening, therapy selection, prenatal health,…
$5.66 (as of 2026-07-22) · market cap $547M
-
LabcorpLHHealth Care
A global diagnostics and drug development laboratory leader that performs 750+ million clinical tests annually and supports 85% of new FDA-approved drugs…
$281.46 (as of 2026-07-22) · market cap $23.1B
-
FULGENT GENETICS INCFLGTHealth Care
Fulgent Genetics develops and offers a broad menu of genetic testing services for molecular diagnostics, helping clinicians interpret patient DNA for disease…
$19.53 (as of 2026-07-22) · market cap $555M
Not quite? Describe exactly what you want →
Peers are ORASURE TECHNOLOGIES INC's closest public companies by shared sub-industry, sector and business themes. See the full profile: ORASURE TECHNOLOGIES INC (OSUR).
Last updated 2026-07-22.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.